Inotrem is currently owned by Sofinnova Partners, through Sofinnova Capital IX, since 2019.

When did Sofinnova Partners acquire Inotrem?

Sofinnova Partners acquired Inotrem in 2019 (active for 7 years).

Home/Companies/Biotech/Inotrem

Inotrem

Biotech·

France·Active·7yr hold

Inotrem is a healthcare / biotech company, headquartered in France.

Entry

2019

Hold

7yr

Status

Active

Est. EV

–

Most recent investor

Sofinnova Partners

2 ownership periods

Key facts

HQFrance

SectorHealthcare / Biotech

French biotech developing novel TREM-1 pathway inhibitors for the treatment of sepsis and other inflammatory conditions.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Capital IX

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings